SEARCH

SEARCH BY CITATION

References

  • Boulle A, Bock P, Osler M, et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 86(9), 678687.
  • Braitstein P, Brinkhof MW, Dabis F, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367(9513), 817824.
  • Brinkhof MW, Boulle A, Weigel R, et al. (2009a) Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Medicine 6(4), e1000066.
  • Brinkhof MW, Dabis F, Myer L, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 86(7), 559567.
  • Brinkhof MW, Pujades-Rodriguez M & Egger M (2009b) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4(6), e5790.
  • Bussmann H, Wester CW, Ndwapi N, et al. (2008) Five-year outcomes of initial patients treated in Botswana’s National Antiretroviral Treatment Program. AIDS 22(17), 23032311.
  • Chan AK, Mateyu G, Jahn A, et al. (2010) Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Tropical Medicine & International Health 15, 9097.
  • Cornell M, Grimsrud A, Fairall L, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS 24(14), 22632270.
  • Egger M, Spycher BD, Sidle J, et al. (2011) Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in Sub-Saharan Africa. PLoS Medicine 8(1), e1000390.
  • Forster M, Bailey C, Brinkhof MW, et al. (2008) Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bulletin of the World Health Organization 86(12), 939947.
  • Fox MP & Rosen S (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Tropical Medicine & International Health 15(Suppl. 1), 115.
  • Harries AD, Zachariah R, Lawn SD & Rosen S (2010) Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Tropical Medicine & International Health 15, 7075.
  • Johansson KA, Robberstad B & Norheim OF (2010) Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS Research and Therapy 7(1), 311.
  • Lowrance DW, Ndamage F, Kayirangwa E, et al. (2009) Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004–2005. Journal of Acquired Immune Deficiency Syndromes 52(1), 4955.
  • May M, Boulle A, Phiri S, et al. (2010) Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376(9739), 449457.
  • Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke GS & Newell ML (2010) Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bulletin of the World Health Organization 88(8), 593600.
  • NACP (2010) Report on the Care and Treatment of HIV in Tanzania 2010. National AIDS Control Programme, Dar es Salaam.
  • Nash D, Katyal M, Brinkhof MW, et al. (2008) Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 22(17), 22912302.
  • Palombi L, Marazzi MC, Guidotti G, et al. (2009) Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral-treated patients in sub-Saharan African Sites with comprehensive monitoring availability. Clinical Infectious Diseases 48(1), 115122.
  • Rosen S & Ketlhapile M (2010) Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. Tropical Medicine & International Health 15, 98104.
  • StataCorp (2009) STATA/IC 11.1. StataCorp, College Station, TX, USA.
  • TACAIDS, ZAC, National Bureau of Statistics, Office of the Chief Government Statistician, Macro International (2008). Tanzania HIV/AIDS and Malaria Indicator Survey 2007–08. TACAIDS, ZAC, NBS, OCGS, Macro International Inc., Dar es Salaam.
  • Tassie JM, Baijal P, Vitoria MA, Alisalad A, Crowley SP & Souteyrand Y (2010) Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries. Journal of Acquired Immune Deficiency Syndromes 54(4), 437441.
  • TRAC (2008) TRAC Report on the Evaluation of Clinical and Immunologic Outcomes from the National Antiretroviral Treatment Program in Rwanda, 2004–2005. Treatment and AIDS Research Centre, Republic of Rwanda.
  • Tweya H, Gareta D, Chagwera F, et al. (2010) Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the ‘Back-to-Care’ project in Lilongwe, Malawi. Tropical Medicine & International Health 15, 8289.
  • UNAIDS (2010) Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. UNAIDS, Geneva.
  • Van Cutsem G, Ford N, Hildebrand K, et al. (2011) Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One 6(2), e14684.
  • WHO (2010) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2010. World Health Organization, Geneva.